To the full analysis
Melexis stock: growth
MELE.BRMelexis reported $930.38M in revenue for fiscal 2025, down 10% on the prior year, up 10.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.8%
per year from 2006 to 2025, per share 8.2%
Earnings (Annual rate)
6.4%
per year from 2006 to 2025, per share 6.8%
Free cash flow (Annual rate)
8.2%
per year from 2006 to 2025, per share 8.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 10.6% | 7.7% | 7.8% |
| Revenue per share | 10.6% | 7.7% | 8.2% |
| Earnings | 10.2% | 1.3% | 6.4% |
| Earnings per share | 10.1% | 1.3% | 6.8% |
| Free cash flow | 6.5% | 2.7% | 8.2% |
| Free cash flow per share | 6.5% | 2.6% | 8.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $223.28M | $38.26M | $24.08M |
| 2007 | $226.11M | $41.09M | $20.05M |
| 2008 | $205.61M | $24.88M | $5.77M |
| 2009 | $142.82M | −$4.42M | $9.67M |
| 2010 | $243.15M | $53.87M | $32.88M |
| 2011 | $255.6M | $50.85M | $48.31M |
| 2012 | $273.75M | $57.1M | $38.46M |
| 2013 | $305.12M | $61.18M | $53.51M |
| 2014 | $368.34M | $94.18M | $79.01M |
| 2015 | $443.39M | $109.78M | $82.79M |
| 2016 | $505.61M | $106.66M | $87.74M |
| 2017 | $566.97M | $122.95M | $74.12M |
| 2018 | $630.92M | $127.93M | $25.96M |
| 2019 | $539.49M | $66.77M | $75.09M |
| 2020 | $562.38M | $76.79M | $78.59M |
| 2021 | $713.38M | $145.28M | $114.29M |
| 2022 | $926.55M | $218.46M | $163.95M |
| 2023 | $1.07B | $232.11M | −$101.08M |
| 2024 | $1.03B | $189.98M | $138.6M |
| 2025 | $930.38M | $124.67M | $107.62M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 12 Nov 2026, previously Neutral
- Valuation signal Fairly valued since 7 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.